Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy an safety results from a randomized, double blind, placebo-controlled trial.

Simple item page
dc.contributor.authorTripathy D
dc.contributor.authorLichinitzer M
dc.contributor.authorLazarev A
dc.contributor.authorMaclachlan SA
dc.contributor.authorApffelstaedt J
dc.contributor.authorBudde M
dc.contributor.authorBergstrom B
dc.date.accessioned2013-01-23T14:11:12Z
dc.date.available2013-01-23T14:11:12Z
dc.date.issued2004
dc.descriptionGesondheidswetenskappe
dc.descriptionChirurgie
dc.descriptionPlease help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za
dc.identifier.citationAnnals of Oncology
dc.identifier.urihttp://hdl.handle.net/10019.1/78677
dc.publisherOXFORD UNIV PRESS, GREAT CLARENDON ST, OXFORD, ENGLAND, OX2 6DP
dc.titleOral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy an safety results from a randomized, double blind, placebo-controlled trial.
dc.typeJournal Articles (subsidised)
Files
Collections
2004 - Research Outputs